Amid the debate over menopausal hormone therapy and cancer risk, researchers at SABCS provided some clarity for women with...
As a regular feature on this blog, we spotlight 10 “must read” articles selected by our editors from each...
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
The AACR-Bayer Innovation and Discovery Grants program supports researchers who are seeking to develop new treatment options for cancers...
Although checkpoint inhibitors and other immunotherapies are remarkably effective for patients with some cancers, demonstrating durable antitumor activity and/or...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...